Wake Forest University Health Sciences
Clinical trials sponsored by Wake Forest University Health Sciences, explained in plain language.
-
New cocktail aims to deeply suppress bone marrow cancer
Disease control OngoingThis study tests a combination of four drugs—daratumumab, carfilzomib, lenalidomide, and dexamethasone—in 39 adults newly diagnosed with multiple myeloma, a blood cancer. The goal is to see how many patients achieve a complete or stringent complete response after initial treatmen…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Virtual coach aims to tame childhood asthma
Disease control OngoingThis study looks at how well a virtual program called Coach McLungs works for children with asthma. The program provides education and helps doctors and families make decisions together. Researchers will track whether kids have fewer asthma attacks and need fewer emergency visits…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
A smarter steroid schedule might tame Chemotherapy's blood sugar spike
Disease control OngoingThis trial tests whether adjusting the dose of prednisone, a steroid in the R-CHOP chemotherapy regimen, can prevent high blood sugar (hyperglycemia) in adults with B-cell non-Hodgkin lymphoma. Participants are randomly assigned to either the standard prednisone dose or a tailore…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New combo therapy shows promise for older AML patients
Disease control OngoingThis study tests whether adding the drug selinexor to standard chemotherapy can help older adults with untreated acute myeloid leukemia (AML) live longer and achieve remission. About 57 participants will receive either standard chemo alone or chemo plus selinexor, followed by mai…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Which psoriasis cream causes less skin discoloration? new study aims to find out
Disease control ENROLLING_BY_INVITATIONThis study compares two standard psoriasis creams—a steroid and a newer drug called tapinarof—to see which one causes less skin color change after treatment. Forty adults with darker skin types will use one cream daily on their legs for up to 12 weeks. Researchers will track pigm…
Phase: PHASE2, PHASE3 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Rural heart patients get virtual lifeline to top specialists
Disease control OngoingThis study looks at whether a telehealth system can help people in rural areas get better heart care. It connects local emergency services and clinics with heart experts at a major medical center. About 215 adults with heart symptoms will take part. The goal is to see if this app…
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Triple threat: new combo aims to tame metastatic prostate cancer
Disease control OngoingThis phase 2 trial tests whether adding enzalutamide to standard hormone therapy and chemotherapy can better control metastatic prostate cancer that still responds to hormones. About 40 men with advanced disease will receive all three drugs. The main goal is to see how many achie…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Triple threat: new combo aims to stop lung cancer in its tracks
Disease control OngoingThis phase II trial tests a three-step approach for stage II or III non-small cell lung cancer. First, the main tumor gets a high-dose radiation blast (SBRT). Then, the chest lymph nodes receive standard radiation plus chemotherapy. Finally, patients get an immunotherapy drug (du…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New hope for metastatic breast cancer: pill combo may replace chemo
Disease control OngoingThis pilot study tests two oral drugs, anastrozole and palbociclib, in postmenopausal women with a common type of metastatic breast cancer (HR+/HER2-). The drugs are given either as the first treatment or as maintenance after chemotherapy. The main goal is to see if the combinati…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a Follow-Up drug deepen remission in myeloma patients?
Disease control OngoingThis study is for people with relapsed multiple myeloma who did not get a complete response after CAR-T cell therapy (idecabtagene vicleucel). Researchers want to see if adding nivolumab, an immunotherapy drug, can improve the depth of response. The trial is in Phase 2 and curren…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New surgical technique aims to reduce cancer margins in vulvar dysplasia
Disease control OngoingThis study tests whether a surgery that uses frozen sections to guide removal (Frozen-Section Directed Excision) works better than the usual wide local excision for high-grade vulvar dysplasia. About 112 adults with confirmed high-grade dysplasia will be randomly assigned to one …
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug cocktail shows promise in battling bone marrow cancer
Disease control OngoingThis study is testing a new drug called belantamab mafodotin when added to three standard chemotherapy drugs (carfilzomib, lenalidomide, and dexamethasone) for people with multiple myeloma, a type of blood cancer. The goal is to find the safest dose and see if this combination ca…
Phase: PHASE1, PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New combo therapy offers hope for head and neck cancer patients who Can't take standard chemo
Disease control OngoingThis phase 2 trial tests a weekly combination of two chemotherapy drugs (carboplatin and paclitaxel) plus the immunotherapy pembrolizumab in 31 patients with metastatic head and neck cancer who cannot receive the standard drug 5-fluorouracil. The goal is to see if this regimen sh…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a common acne gel help stop scarring hair loss?
Disease control OngoingThis early-phase study tests whether azelaic acid gel, a topical medication already used for acne, can help women with central centrifugal cicatricial alopecia (CCCA) — a type of scarring hair loss that mainly affects Black women. Eighteen women will use the gel on their scalp on…
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Cash for clean tests: App-Based rewards tested in older drug users
Disease control OngoingThis study tests whether an app that gives financial rewards for drug-negative saliva tests works for older adults with opioid, cocaine, or methamphetamine use disorder. Researchers will compare results between older and younger participants to see if age affects how well the app…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Dialysis dilemma: which access surgery is safer for seniors?
Disease control OngoingThis study compares two types of surgery to create dialysis access in older adults (60+) with end-stage kidney disease. One method connects a vein directly to an artery (fistula), the other uses a synthetic tube (graft). The goal is to see which leads to fewer infections and more…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a direct brain artery injection improve stroke recovery?
Disease control ENROLLING_BY_INVITATIONThis phase 2 trial tests whether giving the clot-busting drug tenecteplase directly into the brain artery after standard clot removal is safe and feasible for people with severe stroke. About 40 participants who had a large artery blockage will receive either the drug or a saltwa…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New cocktail of drugs takes on tough breast cancer
Disease control OngoingThis phase II trial is testing a combination of four drugs—trilaciclib, pembrolizumab, gemcitabine, and carboplatin—in people with advanced triple-negative breast cancer that cannot be removed by surgery or has spread. The study aims to see how well the treatment works and how sa…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a phone call keep your blood pressure in check after a stroke?
Disease control OngoingThis study compares two ways to help stroke survivors control their blood pressure using telehealth. About 86 participants will receive either enhanced remote monitoring or standard care. The goal is to see which approach better helps people reach a safe blood pressure target and…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Which sling is best for leakage? new trial compares One-Cut vs. Two-Cut methods
Disease control OngoingThis study compares two types of sling surgery for stress urinary incontinence (leaking urine with cough or sneeze) in women who are also having surgery for pelvic organ prolapse. One sling uses a single incision, the other uses two incisions. The trial will enroll 180 women and …
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a 60-year-old diet pill work for years? new study aims to find out.
Disease control OngoingThis study tests whether the weight-loss drug phentermine, currently approved for only 12 weeks, can be safely used for up to 2 years. About 870 adults with obesity will take phentermine and receive online lifestyle coaching. Researchers will track weight loss, blood pressure, an…
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Dance your way to a sharper mind: study tests best weekly dose for brain health
Disease control OngoingThis study looks at how often older adults (62+) who are worried about memory loss should take dance or music classes to boost brain health and physical fitness. Over 6 months, 165 participants will attend 1, 2, or 3 group classes per week. Researchers will measure changes in mem…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Fat cell knee injection trial for Post-Trauma arthritis pulled before start
Disease control TerminatedThis pilot trial aimed to test the safety and feasibility of a single injection of a patient's own fat-derived cells (stromal vascular fraction) into the knee for post-traumatic osteoarthritis. It was designed for adults aged 18–45 with a history of knee injury. However, the stud…
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Stem cells from amniotic fluid tested for progressive MS – but trial pulled
Disease control TerminatedThis study aimed to test whether stem cells from amniotic fluid, injected into the spinal fluid, could safely help people with progressive multiple sclerosis (MS). The trial was designed for adults aged 18–60 with primary or secondary progressive MS. However, the study was withdr…
Phase: PHASE1, PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Liver drug study for rare disease pulled before it started
Disease control TerminatedThis study aimed to see if the drug bitopertin is safe for people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) who also have early signs of liver disease. Researchers planned to check for side effects and measure changes in protoporphyrin levels in bl…
Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a Weight-Loss drug protect muscle and bone in seniors? new study aims to find out
Disease control OngoingThis pilot study is testing the drug tirzepatide (Zepbound) in 40 older adults with obesity to see how it affects body composition, bone density, and physical function over nine months. Participants take weekly injections, track their diet and activity, and attend regular check-i…
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Fish oil treatment offers hope for babies with liver damage from IV nutrition
Disease control APPROVED_FOR_MARKETINGThis study provides expanded access to Omegaven, a fish oil infusion, for infants and children up to 18 years old who have developed liver disease from long-term IV nutrition. The goal is to lower high liver enzymes and bilirubin levels. Participants must be dependent on IV nutri…
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a sticky patch replace the dreaded sugar drink test for new moms?
Diagnosis ENROLLING_BY_INVITATIONThis study is testing whether a continuous glucose monitor (CGM) worn on the arm for 14 days can replace the standard oral glucose tolerance test (OGTT) for women who had gestational diabetes. Many women find the OGTT burdensome and skip it, missing a chance to catch lingering bl…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC
-
Which estrogen treatment do women prefer to prevent recurrent UTIs?
Prevention OngoingThis study looks at two forms of vaginal estrogen—cream and tablet—to see which one post-menopausal women prefer for preventing recurrent urinary tract infections (UTIs). About 21 women who have had multiple UTIs will try both treatments and then choose their favorite. The goal i…
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Jun 27, 2026 08:00 UTC
-
New online program aims to ease pain for cancer survivors
Symptom relief OngoingThis study tests whether an internet-based pain coping skills program can help cancer survivors manage ongoing pain. About 456 adults who have completed cancer treatment or are on maintenance therapy will take part. Participants will either get the online program plus enhanced us…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Shock therapy for needle pain: TENS device tested on psoriasis patients
Symptom relief OngoingThis study tests whether a TENS (transcutaneous electrical nerve stimulation) device can reduce the pain of biologic injections in people with psoriasis. About 20 adults will receive their injection in one thigh without TENS and in the other thigh with TENS pads placed nearby. Th…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Love hormone may speed up hip replacement recovery
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a single intravenous dose of oxytocin, given during hip replacement surgery, can help people recover faster. Researchers will track daily steps for 56 days in 80 adults aged 18–75. If successful, oxytocin could become a simple way to boost mobility after …
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
New study tests At-Home programs to ease pain and anxiety after cancer surgery
Symptom relief OngoingThis study compares two different remote support programs to see which one helps women feel better after surgery for suspected gynecological cancer. About 160 women will take part, and researchers will measure pain, mood, and sleep quality. The goal is to find simple, at-home way…
Phase: PHASE3 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Community health workers step in to boost palliative care for black cancer patients
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether adding a trained community health worker (CHW) to standard care can improve quality of life and advance care planning for African American patients with advanced cancer. 160 patients will either receive standard care or standard care plus CHW support. The…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Could a magnetic mat ease bladder pain? small trial aims to find out
Symptom relief TerminatedThis study tests whether adding pulsed electromagnetic field (PEMF) therapy to standard bladder instillations of heparin and bupivacaine can better reduce chronic pelvic pain in women with interstitial cystitis/bladder pain syndrome. Twenty female adults who already receive bladd…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New online program aims to ease burden on lung cancer caregivers
Symptom relief OngoingThis study tests a new web-based tool called CONNECT, designed to help caregivers of people with stage II to IV lung cancer find support resources. About 216 caregivers will use the tool and have sessions with a navigator to see if it helps them feel more supported. The goal is t…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New razor tech aims to soothe shaving irritation
Symptom relief OngoingThis study tests whether a new razor, used alone or with a pre-shave gel and brush, can improve shaving satisfaction and reduce skin irritation in men with razor bumps. Forty men with mild to moderate symptoms will use the products for 12 weeks. The goal is to see if the new appr…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Mindfulness or diet? study aims to soothe IBS without drugs
Symptom relief TerminatedThis study planned to compare a mindfulness-based eating awareness program with the standard low-FODMAP diet for people with irritable bowel syndrome (IBS). The goal was to see which approach better improves IBS symptoms. However, the study was withdrawn before enrolling any part…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can spreading out brain radiation reduce side effects for immunotherapy patients?
Symptom relief OngoingThis study looks at two ways to give radiation to brain tumors in people who are also receiving immunotherapy for cancers like lung, breast, kidney, or melanoma. The standard approach gives one high dose of radiation, while the experimental approach gives smaller doses over sever…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New online program aims to ease sexual distress in breast cancer survivors
Symptom relief OngoingThis study tests an internet-based program called SHINE to help breast cancer survivors manage sexual concerns after treatment. About 340 women who finished primary cancer treatment at least 12 weeks ago will join. Participants get online education and tools, and the study checks…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Can a brainwave device cure nurse burnout? small study hopes to find out
Symptom relief ENROLLING_BY_INVITATIONThis study tests a device called Cereset that plays tones to mirror your brainwaves, aiming to reduce stress, anxiety, insomnia, and depression. About 40 nurses from one hospital unit will use the device. The goal is to see if it improves their well-being and job performance.
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Migraine procedure trial pulled before it even started
Symptom relief TerminatedThis pilot study aimed to see if blocking a specific artery in the brain could help people with chronic migraines that don't respond to drugs. The procedure, called middle meningeal artery embolization, uses tiny particles or coils to block the vessel. However, the study was with…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Desperate patients get access to unapproved drug for stomach paralysis
Symptom relief NO_LONGER_AVAILABLEThis program allows people aged 12 and older with severe stomach or gut problems, like gastroparesis, to try domperidone when standard treatments have failed. The goal is to ease symptoms such as nausea, vomiting, and severe indigestion. The drug is not FDA-approved but is availa…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New stitch could cut surgery time for pelvic organ prolapse
Symptom relief OngoingThis study compares two types of stitches used during minimally invasive surgery for pelvic organ prolapse in women. The goal is to see if barbed sutures (which hold tissue without knots) can attach the vaginal mesh faster than traditional interrupted sutures. Fifty-two women wil…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Calcium supplement may speed up labor and cut C-Sections
Symptom relief OngoingThis pilot study tests whether giving calcium carbonate to pregnant women during labor induction can shorten the time needed and reduce the need for C-sections. Researchers will compare 250 women who receive calcium with a historical control group. The goal is to see if this simp…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Exercise as a potential remedy for chronic bladder pain?
Symptom relief TerminatedThis study planned to see if a 6-week supervised exercise program could reduce symptoms of interstitial cystitis (painful bladder syndrome) and improve quality of life in adult women. Participants would have walked and done light strength training three times a week. However, the…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Gentian violet study for painful skin condition pulled before it began
Symptom relief TerminatedThis study planned to test whether gentian violet, a common purple antiseptic, could reduce redness, drainage, and pain in people with hidradenitis suppurativa (HS). Participants would have applied the treatment once and returned a month later to report changes. However, the stud…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 26, 2026 13:55 UTC
-
Blood test may help cancer patients avoid nerve damage from chemo
Knowledge-focused TerminatedThis pilot study aims to see if doctors can consistently measure paclitaxel levels in the blood of cancer patients receiving the drug. The goal is to eventually adjust doses to give enough chemo to fight cancer while reducing the common side effect of nerve damage. The study invo…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Lab-Grown 3D tumors could help pick the right chemo for blood cancer patients
Knowledge-focused OngoingThis study uses bone marrow samples from 70 people with blood cancers to create 3D organoids—tiny lab-grown models that mimic the tumor's environment. Researchers will test different chemotherapy combinations on these organoids to see which kills the most cancer cells. The goal i…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can a simple screening catch memory issues after ICU? new study says maybe.
Knowledge-focused OngoingThis study tested a program that screens older adults (60+) for memory and thinking problems after they leave the intensive care unit (ICU). The goal was to see if it's possible to identify issues like mild cognitive impairment or dementia early. 109 people took part, and the stu…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
New bedside heart test could slash ER wait times for chest pain
Knowledge-focused OngoingThis study looks at whether a quick, point-of-care blood test for heart damage can give results faster than standard lab tests for people with chest pain in the emergency room. Researchers will compare the time it takes to get test results and how long patients stay in the ER. Th…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Gene test could personalize cancer drug dosing
Knowledge-focused OngoingThis study looks at whether a broad genetic test (microarray PGx) can find more drug-gene interactions than the standard single-gene test in 120 adults with cancer who are about to receive chemotherapy. The goal is to see if this extra information could help doctors adjust drug d…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Cancer clinics study how to spot Patients' hidden struggles
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how community cancer clinics screen for health-related social needs, like help with housing, food, or transportation. Researchers will work with 144 clinic staff to understand what helps or hinders screening. The goal is to create custom plans to make screenin…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Single-Dose radiation during lumpectomy: a new option for early breast cancer?
Knowledge-focused OngoingThis registry follows 94 women aged 50 and older with early-stage, low-risk breast cancer who received a single dose of radiation directly to the tumor site during lumpectomy (IORT). The goal is to monitor cancer recurrence, side effects, and patient satisfaction over time. Becau…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Brain scans aim to unlock mysteries of muscle disease
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how myotonic dystrophy types 1 and 2 affect the brain. About 100 adults aged 30-65 will have MRI scans, thinking and movement tests, and blood draws. Some will also have a spinal tap. The goal is to find brain changes that could be used as markers in future tr…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Lung cancer radiation study tests simpler breath hold method
Knowledge-focused OngoingThis study looks at two methods for keeping the lungs still during radiation treatment for lung cancer. One method uses a special camera system (SGRT) alone, and the other adds small implanted markers (fiducials) for extra guidance. The goal is to see which approach is more relia…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Younger women may feel more pain from chemo support drug, study suggests
Knowledge-focused OngoingThis study is looking at whether younger women (45 and under) feel more pain from a drug called pegfilgrastim, which is given during chemotherapy for breast cancer, compared to older women. About 115 women will report their pain levels and have their blood counts checked. The goa…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Can a simple program help more kidney patients get transplants?
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows about 793 people with chronic kidney disease who previously took part in a program designed to help them talk to doctors and family about kidney transplants. Researchers want to see if the program's effects last over time, including whether patients start trans…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Surgery insight: how hernia repair affects the stomach valve
Knowledge-focused OngoingThis study looks at how hiatal hernia repair surgery changes the flexibility of the junction between the esophagus and stomach. Researchers will use a special balloon device during surgery to measure this flexibility in 25 adults. They hope to find links between these measurement…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Zapped nerves: study planned to boost recovery after surgery — but never started
Knowledge-focused TerminatedThis study was designed to see if giving a short, mild electrical stimulation to compressed nerves during surgery could speed up recovery of strength and function. It planned to include people with nerve compression in the spine or limbs who were already scheduled for decompressi…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Study tests best way to warn about cannabis edibles
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how different warning labels on cannabis edibles packaging change what people know, how safe they think the product is, and whether they want to try it. About 1,250 adults in the U.S. will view packages with different warnings and answer questions. The goal is…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Gene study aims to boost kidney transplant success for african americans
Knowledge-focused OngoingThe APOLLO study looks at how variations in the APOL1 gene, common in people of African ancestry, affect kidney transplant outcomes. Researchers are testing DNA from 5,000 kidney donors and recipients to see if certain gene variants lead to faster kidney failure or harm living do…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Pilot study checks if DHA screening is practical for pregnant women
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether it is practical to offer a blood test for DHA (a nutrient important for baby's brain development) to all pregnant women early in their care. About 650 patients starting prenatal care at participating clinics will be invited to take the test. The main g…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Leftover surgery tissue put to use in lab research
Knowledge-focused ENROLLING_BY_INVITATIONThis study takes tissue that would normally be thrown away after surgery and uses it to grow cells in the lab. The goal is to develop better ways to study and repair tissues in the future. Up to 1,000 people having surgery at Wake Forest may participate. There is no direct benefi…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Blood markers may reveal which lung cancer patients stay Cancer-Free after treatment
Knowledge-focused OngoingThis study follows 23 people with advanced non-small cell lung cancer who have finished at least 20 months of immunotherapy. Researchers collect blood and tissue samples to look for DNA and immune system markers that might predict if the cancer will come back within 6 months. The…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to improve cancer care for seniors
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether training and support can help cancer clinics give special check-ups (called geriatric assessments) to patients aged 65 and older who are starting a new cancer treatment. These check-ups help find and address health issues, support needs, and daily life…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Study on sepsis Patients' data sharing withdrawn before starting
Knowledge-focused TerminatedThis study aimed to see if supportive text messages help sepsis patients track and share their health data after leaving the hospital. It was withdrawn before enrolling anyone, so no results are available. The goal was to improve how patient-reported information is collected and …
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Moisturizer Check-Ins may boost skin health in eczema patients
Knowledge-focused OngoingThis study looks at whether tracking how often people use moisturizer can help treat dry skin caused by eczema. Thirty adults with dry skin will receive a moisturizer and be split into three groups: one with no extra help, one with weekly surveys, and one using a device to measur…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Texting patients could boost psoriasis drug success
Knowledge-focused OngoingThis study looks at whether weekly text reminders help people with psoriasis take their deucravacitinib medication as prescribed. Forty patients will be split into two groups: one gets reminders, the other does not. Researchers will interview participants to understand what helps…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Checklist aims to protect endoscopists from repetitive strain injuries
Knowledge-focused TerminatedThis study was designed to test whether a special checklist bundle (SCOPE-E) could help doctors who perform colonoscopy avoid work-related injuries. The trial planned to enroll endoscopists at multiple centers and measure their posture during procedures using an AI program. Howev…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Acne Patients' medication habits under the microscope
Knowledge-focused OngoingThis study tracks how consistently 72 adults with acne use their prescribed topical medications. Researchers measure adherence by weighing bottles and using electronic monitors to count doses. The goal is to identify barriers like cost, side effects, or forgetfulness that cause p…
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Scientists hunt for early Alzheimer's warning signs in brain scans
Knowledge-focused ENROLLING_BY_INVITATIONThis study uses a special brain scan to measure amyloid protein buildup in 800 people already enrolled in an Alzheimer's research center. The goal is to understand when amyloid starts accumulating and how fast it builds up, which could reveal a window for early treatment. Partici…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Can chemotherapy harm your heart? new study investigates
Knowledge-focused OngoingThis study looks at how chemotherapy for breast cancer affects the heart, exercise ability, and fatigue. Researchers will compare breast cancer patients to people without cancer using heart MRIs and walking tests. The goal is to better understand and predict heart-related side ef…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC